The new app provides user with more features, including an AI-powered search, than the pharmacy’s previous app.
Stock.adobe.com
While most of the discussion surrounding technology and pharma is focused on how drug developers are creating, producing, and commercializing new medications, it’s important to remember that technology can improve the ways that patients actually get the drugs that they need.
CVS Health announced a new app focused on making drugs more accessible and affordable.1 The CVS Health app replaces the company’s previous app, CVS Pharmacy.
The new platform allows users to manage subscriptions for an entire across all of CVS’ brands, access to health spending and benefit details, and immunization scheduling. It also creates personalized barcodes for each user which can be used to expedite in-store prescription pick-ups.
Users will also have access to health recommendations, an AI-powered search, and more health and wellness content.
In a press release, CVS Health executive vice president Tilak Mandadi said, “As a company, we are super focused on improving the health care experience. The CVS Health app will make it easier for our customers to access and manage their health and care, save time and money, and make informed decisions about their health."
Tony Ambrozie, senior vice president and chief digital and technology officer at CVS Health Pharmacy and Consumer Wellness, added, “The app is the health concierge and guide for all consumers. With 60 million digital customers, we are excited to continue to innovate and bring best-in-class and first-in-industry capabilities to our customers."
Aside from updating its app, CVS has taken other steps to support patients. The company recently announced that it was providing $4 million in grants to various health agencies across the country as part of its healthy aging initiative.2 The goal of these grants was to help these organizations improve health care access and resources for aging patients suffering from brain, heart, and behavioral conditions.
In a press release issued at the time, CVS Health’s senior vice president of corporate social responsibility and chief sustainability officer Sheryl Burke said, “People over the age of 65 are enjoying longer, more active lives and make up the largest generation of older adults in U.S. history. We're excited to work with each of these organizations that are making a significant impact by preparing and providing the health care and resources our communities need for the generational shift of aging Americans."
Jeffrey M. Smythe, executive director of Atlanta Regional Collaborative for Health Improvement (one of the grant recipients) also said, “Collaboration—like here with the CVS Health Foundation—has shown us that when we work together, we can indeed invert the burden from those who have traditionally been left out of good health, including many of our city's underserved elders. The system can indeed bear that burden, we can change the system of care to be more person-centered, and we look forward to this opportunity to further expand the work of these dedicated partners."
Caitlin Behringer of Open Hand Atlanta (one of the other recipients) added, “We saw tremendous results through our nutrition interventions that were provided to members of the Community Resource Hub, and we know we will continue to see significant improvements in older adults' health outcomes. Leaders from across multiple of these sectors have come together today because we know this can be a game-changer and we can provide significant improvements to the systems of care for our most marginalized older adults and their caregivers."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.